Terms: = Head and neck cancer AND HRAS, K-ras, 3265, ENSG00000174775, HRAS1, RASH1, c-bas/has, P01112, N-ras
720 results:
1. Therapeutic Advances and Challenges for the Management of HPV-Associated Oropharyngeal cancer.
Muniz IAF; Araujo M; Bouassaly J; Farshadi F; Atique M; Esfahani K; Bonan PRF; Hier M; Mascarella M; Mlynarek A; Alaoui-Jamali M; Silva SDD
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612819
[TBL] [Abstract] [Full Text] [Related]
2. Unraveling the Genetic Web: H-Ras Expression and Mutation in Oral Squamous Cell Carcinoma-A Systematic Review.
Devi P; Dwivedi R; Sankar R; Jain A; Gupta S; Gupta S
Head Neck Pathol; 2024 Mar; 18(1):21. PubMed ID: 38502412
[TBL] [Abstract] [Full Text] [Related]
3.
Sfreddo HJ; Koh ES; Zhao K; Swartzwelder CE; Untch BR; Marti JL; Roman BR; Dublin J; Wang RS; Xia R; Cohen JM; Xu B; Ghossein R; Givi B; Boyle JO; Tuttle RM; Fagin JA; Wong RJ; Morris LGT
Thyroid; 2024 Apr; 34(4):450-459. PubMed ID: 38407967
[No Abstract] [Full Text] [Related]
4. Identification of Germline
Pires C; Saramago A; Moura MM; Li J; Donato S; Marques IJ; Belo H; Machado AC; Cabrera R; Grünewald TGP; Leite V; Cavaco BM
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396644
[TBL] [Abstract] [Full Text] [Related]
5. The Role of 5-Hydroxymethylcytosine as a Potential Epigenetic Biomarker in a Large Series of Thyroid Neoplasms.
Canberk S; Gonçalves J; Rios E; Povoa AA; Tastekin E; Sobrinho-Simões M; Uguz A; Aydin O; Ince U; Soares P; Máximo V
Endocr Pathol; 2024 Mar; 35(1):25-39. PubMed ID: 38285158
[TBL] [Abstract] [Full Text] [Related]
6. Clinical value of multi-gene testing in distinguishing benign and malignant thyroid nodules.
Zhang M; Hu X; Liu L; Wang Y; Jiang J; Li H; Fei W; Zhong T; Jiang Z
Medicine (Baltimore); 2024 Jan; 103(4):e35960. PubMed ID: 38277563
[TBL] [Abstract] [Full Text] [Related]
7. Evolutionary dynamics of tipifarnib in hras mutated head and neck squamous cell carcinoma.
Jagadeeshan S; Suryamohan K; Shin N; Mathukkada S; Boyko A; Melikhova D; Tsareva A; Yunusova L; Pravdivtseva E; Stupichev D; Shaposhnikov K; Peterson A; Bednyagin L; Shugaev-Mendosa E; Kessler L; Burrows F; Ho AL; Agrawal N; Pearson AT; Izumchenko E; Cole G; Elkabets M; Rosenberg AJ
Oral Oncol; 2024 Feb; 149():106688. PubMed ID: 38219706
[TBL] [Abstract] [Full Text] [Related]
8. Gene mutation analysis of oral submucous fibrosis cancerization in Hainan Island.
Li B; Chen X; Xian H; Wen Q; Wang T
PeerJ; 2023; 11():e16392. PubMed ID: 38050610
[TBL] [Abstract] [Full Text] [Related]
9. Fine-needle biopsy of thyroid nodules and the contribution of molecular analysis of BRAF and RAS mutations.
Kasko M; Grigerova M; Alemayehu A; Zavodna K; Kasko V; Podoba J
Bratisl Lek Listy; 2023; 124(12):869-872. PubMed ID: 37983279
[TBL] [Abstract] [Full Text] [Related]
10. Sialadenoma papilliferum-like intraductal papillary tumour: an emerging entity with intercalated duct differentiation showing MAPK pathway activation in both ductal and myoepithelial cells.
Oh KY; Kim JH; Hong SD; Yoon HJ
Pathology; 2024 Feb; 56(1):52-58. PubMed ID: 37973455
[TBL] [Abstract] [Full Text] [Related]
11. Inhibition of transforming growth factor-β signals suppresses tumor formation by regulation of tumor microenvironment networks.
Tokizaki S; Podyma-Inoue KA; Matsumoto T; Takahashi K; Kobayashi M; Ibi H; Uchida S; Iwabuchi S; Harada H; Hashimoto S; Miyazono K; Shirouzu M; Watabe T
Cancer Sci; 2024 Jan; 115(1):211-226. PubMed ID: 37972575
[TBL] [Abstract] [Full Text] [Related]
12. Whole exome sequencing uncovers hras mutations as potential mediators of resistance to metronomic chemotherapy.
Sambath J; Noronha V; Manda SS; Mishra R; Chandrani P; Patil V; Menon N; Chougule A; Ramachandran V; Limaye S; Kuriakose MA; Banavali SD; Kumar P; Prabhash K
Gene; 2024 Jan; 893():147952. PubMed ID: 37918550
[TBL] [Abstract] [Full Text] [Related]
13. TERT promoter mutation positive oral cavity carcinomas, a clinically and genetically distinct subgroup of head and neck squamous cell carcinomas.
Saito Y; Kage H; Kobayashi K; Yoshida M; Fukuoka O; Yamamura K; Mukai T; Oda K; Yamasoba T
Head Neck; 2023 Dec; 45(12):3107-3118. PubMed ID: 37815002
[TBL] [Abstract] [Full Text] [Related]
14. To Tip or Not to Tip: A New Combination for Precision Medicine in head and neck cancer.
Lee RH; Johnson DE; Grandis JR
Cancer Res; 2023 Oct; 83(19):3162-3164. PubMed ID: 37779427
[TBL] [Abstract] [Full Text] [Related]
15. Macrofollicular Architecture in Invasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Pitfall in Thyroid Practice.
Yadav S; Kandasamy D; Damle N; Goel R; Chumber S; Sharma MC; Boruah M; Agarwal S
Head Neck Pathol; 2023 Dec; 17(4):899-909. PubMed ID: 37775618
[TBL] [Abstract] [Full Text] [Related]
16. Clear Cell Squamous Cell Carcinoma of the Maxillary Gingiva Associated with PIK3CA and hras Mutations: Report of a Case and Literature Review.
Hirose K; Shibahara T; Teramoto A; Usami Y; Ono S; Iwamoto Y; Murakami S; Oya K; Uzawa N; Motooka D; Hori Y; Morii E; Toyosawa S
Head Neck Pathol; 2023 Dec; 17(4):1026-1033. PubMed ID: 37735286
[TBL] [Abstract] [Full Text] [Related]
17. Mutant hras Signaling and Rationale for Use of Farnesyltransferase Inhibitors in head and neck Squamous Cell Carcinoma.
Wang J; Al-Majid D; Brenner JC; Smith JD
Target Oncol; 2023 Sep; 18(5):643-655. PubMed ID: 37665491
[TBL] [Abstract] [Full Text] [Related]
18. Oncogenic Ras and ΔNp63α cooperate to recruit immunosuppressive polymorphonuclear myeloid-derived suppressor cells in a mouse model of squamous cancer pathogenesis.
Sakakibara N; Clavijo PE; Sievers C; Gray VC; King KE; George AL; Ponnamperuma RM; Walter BA; Chen Z; Van Waes C; Allen CT; Weinberg WC
Front Immunol; 2023; 14():1200970. PubMed ID: 37638000
[TBL] [Abstract] [Full Text] [Related]
19. The histologic outcomes of indeterminate thyroid nodules with rat sarcoma mutations: A case series.
Jones M; Abendano DG; Turner M; Sullivan C; Reyes MCD
Diagn Cytopathol; 2023 Dec; 51(12):E332-E337. PubMed ID: 37583345
[TBL] [Abstract] [Full Text] [Related]
20. Branchioma with a nested/organoid morphology: molecular profiling of a distinctive potentially misleading variant and reappraisal of potential relationship to CD34-positive/Rb1-deficient tumors of the neck.
Baněčková M; Michal M; Vaněček T; Grossman P; Nikolov DH; Včelák R; Žalud R; Michal M; Agaimy A
Virchows Arch; 2023 Oct; 483(4):541-548. PubMed ID: 37401932
[TBL] [Abstract] [Full Text] [Related]
[Next]
